Corporate, October 2025

TT&A advised WestBridge Capital in TrueMeds’s USD 85 Million Series C Round led by Accel and Peak XV

TT&A advised and assisted WestBridge AIF I along with co-investors MMPL Trust and Konark Trust(collectively referred to as “WestBridge Capital”) in their investment into Intellihealth Solutions Private Limited (“Company”) as part of the USD 85 Million Series C Round led by Accel and Peak XV.

WestBridge Capital invested in TrueMeds by way of a combination of primary and secondary investment with purchase of shares from the certain existing shareholders of the Company (including the founders, IAN Fund I and individual angel investors).

ANKW Pharma Retail Private Limited, a wholly owned subsidiary of the Company, runs a tele-health platform, that provides teleconsultation, home delivery of medicines and healthcare products, and other related services and principally operates under the popular brand name “Truemeds”.

TT&A Team: Gautam Saha – Joint Managing Partner;  Amrita Patnaik & Harshit Chandra – Partners; Utsav Agarwal – Managing Associate; Shambhavi Singh – Senior Associate and Radhika Sarda – Associate 

Gautam Saha

Joint Managing Partner, Delhi

Amrita Patnaik

Partner, Delhi

Harshit Chandra

Partner, Delhi

Disclaimer

By browsing this website you agree that you are, of your own accord, seeking further information regarding TT&A. No part of this website should be construed as an advertisement of or solicitation for our professional services. No information provided on this shall be construed as legal advice.